IGF-IR activation further amplifies disease progression by engaging both the Ras/Raf/MEK/ERK and PI3K/Akt pathways, forming a dual-pathway synergy that promotes tumor cell growth and exacerbates hematologic malignancies. Here, IGF1R is linked to neoplasm.